How to Buy Aridis Pharmaceuticals Stock
Aridis Pharmaceuticals Inc
Aridis Pharmaceuticals, Inc. , a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections.
Aridis Pharmaceuticals stock last closed at $0.36, down 1.91% from the previous day, and has decreased 76.92% in one year. It has underperformed other stocks in the Biotechnology industry by 0.53 percentage points. Aridis Pharmaceuticals stock is currently +2.86% from its 52-week low of $0.35, and -87% from its 52-week high of $2.77.
There are currently 20.8M shares of ARDS outstanding. The market capitalization of ARDS is $7.49M. In the last 24 hours, 335,642 ARDS shares were traded.
How to Buy Aridis Pharmaceuticals Stock
Wondering how to invest in Aridis Pharmaceuticals stock? Here's how.
- Choose where to buy Aridis Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Aridis Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Choose your method of payment and add your info.
- Research Aridis Pharmaceuticals stock: The Aridis Pharmaceuticals ticker symbol is ARDS. Is Aridis Pharmaceuticals stock a good investment? Should you buy shares of ARDS? How do ARDS's underlying business fundamentals look? Do top analysts think Aridis Pharmaceuticals is a good buy? Why has ARDS's stock price moved recently? (Hint: Our stock market research website can help you decide if ARDS is a good stock to buy).
- Execute your ARDS purchase: Decide if you will purchase ARDS shares at the current market price or use a limit order to buy ARDS stock at a specific price.
- Watch your ARDS position: Create a watchlist to key updates about your investment in Aridis Pharmaceuticals shares.
Step 1: Choose where to buy Aridis Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy ARDS stock.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by opening an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal info so you are able to invest in ARDS stock today.
How to Set Up a New Account on eToro
- Click here to get started.
- Input your personal info to open a new brokerage account.
- Send your application by clicking the "Create Account" button.
Step 3: Put funds into your investment account
Now that you've opened your account on our top ranked stock app, your next step is to transfer the money for your investment:
Watch the walkthrough below if you need help depositing money into your investment account.
Step 4: Research Aridis Pharmaceuticals stock
After you have figured out the best place to buy Aridis Pharmaceuticals stock, it's important to research their stock prior to investing, so you truly understand the risk as well as the upside.
Aridis Pharmaceuticals shares data
Aridis Pharmaceuticals Overview
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on ARDS's stock page.
Is ARDS stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ARDS's intrinsic value.
You can do more valuation analysis on ARDS's stock here.
A look at ARDS Cashflows and Balance Sheet
Signs that ARDS is financially healthy:
- There are more short-term assets than long-term liabilities on the ARDS balance sheet.
Signs that ARDS is not financially healthy:
- ARDS debt to equity ratio of -1.34 is negative.
- Total ARDS debt is still negative.
- There are more short-term liabilities than short-term assets on the ARDS balance sheet.
- ARDS has $2.63M in cash and short term investments. This is not sufficient to cover its annual cash burn of $24.29M.
- ARDS profit margin has gone up by 67.63 percentage points in the past year, but the company is still unprofitable.
- ARDS has cash burn of 24289000. It does not have sufficient cash and short-term investments to cover this.
Do Wall Street analysts think it's a good time to buy Aridis Pharmaceuticals stock
Out of 2 sell side analysts who give ratings on ARDS, the consensus analyst rating on Aridis Pharmaceuticals is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest ARDS Analyst Forecasts
Vernon Bernardino, a top 17% analyst from HC Wainwright & Co. maintains ARDS with a buy rating and lowers their ARDS price target from $19.00 to $10.00, on Jan 26, 2023.
Jason McCarthy, a bottom 2% analyst from Maxim Group downgrades ARDS to a hold rating, on Aug 16, 2022.
You can dive deeper into what analysts are projecting on the Aridis Pharmaceuticals stock forecast page.
ARDS Trading Indicators
ARDS Revenue
Last year, ARDS revenue was $2.87M. During the past 4 year, ARDS's revenue has grown by 7.33% per year. This was slower than the Biotechnology industry average of 50.9%.
Find out more about ARDS's earnings and revenue performance here.
Who is buying/selling ARDS?
Over the past 12 months, executives and large shareholders at ARDS have not bought or sold any shares.
Get more info about who owns ARDS stock here.
Can I rely on ARDS as an income stream?
No, Aridis Pharmaceuticals doesn't provide an income stream by paying out dividends.
ARDS Social Trading Data
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your ARDS purchase
You have two primary options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular price, place a limit order.
Press the Open Trade button and your broker will place your order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
Step 6: Watch your ARDS position
Now that you own some ARDS shares, you'll want to keep up with your investment.
Make a watchlist to get notified of the latest news about your ARDS stock.
ARDS Feed
How to Buy Stock in Aridis Pharmaceuticals
To reiterate, here are the 6 steps to buy Aridis Pharmaceuticals stock:
- Choose where to buy Aridis Pharmaceuticals stock
- Create your brokerage account
- Put funds into your investment account
- Research Aridis Pharmaceuticals stock
- Execute your ARDS purchase
- Watch your ARDS position
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your investment in Aridis Pharmaceuticals, create a watchlist on WallStreetZen today.
Trending "How To" Guides
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.